Sir Andrew Witty will continue in his current role at Optum while overseeing enterprise business development for UnitedHealth Group.
UnitedHealth Group (UHG) announced this week that Sir Andrew Witty, CEO of its subsidiary Optum, would serve as president of the company.
Witty, who has led Optum since March 2018, will continue in his current role while also overseeing enterprise business development for UHG.
“I’m confident that expanding Andrew’s strategic insights more broadly across the company will help accelerate the next phase of innovation and growth at UnitedHealth Group as we focus on building and shaping the next generation health system in a socially conscious way," David Wichmann, CEO of UHG, said in a statement.
The Minnetonka, Minnesota-based insurer made the announcement about one month after releasing its Q3 earnings report, which was buoyed by strong performance from Optum.
The subsidiary reported $28.8 billion in revenues and $2.4 billion in earnings from operations.
Additionally, OptumRx revenues increased 5.8% year-over-year, totaling $18.5 billion in Q3.
Prior to joining UHG, Witty served as CEO of GlaxoSmithKline, a London–based drugmaker, from 2008 to 2017.
Jack O'Brien is the finance editor at HealthLeaders, a Simplify Compliance brand.
Photo credit: KIEV, UKRAINE - Dec 10, 2018: UnitedHealth Group Managed care company logo seen displayed on smart phone. - Image / Editorial credit: IgorGolovniov / Shutterstock.com